A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma

A meta-analysis: the clinical value of PD-1 inhibitor or protein tyrosine kinase inhibitors in the treatment of advanced osteosarcoma

BackgroundsPD-1 inhibitors and TKIs have been used to treat advanced osteosarcoma, but there is still a lack of intuitive data for the comparison of their efficacy. We conducted a meta-analysis to evaluate their therapeutic benefits.MethodsA systematic methodological search of five primary electroni...

Full description

Bibliographic Details
Main Authors: Binhao Shi, Junli Chang, Xingyuan Sun, Xiaoping Ma, Peng Zhao, Chujie Zhou, Yongjun Wang, Yanping Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
PD-1 inhibitors
protein tyrosinase inhibitors
advanced osteosarcoma
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1148735/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1148735/full

Similar Items